Diffusion-weighted Imaging Magnetic Resonance for Assessing Liver Fibrosis

NACompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Fibrosis, Liver
Interventions
DEVICE

Diffusion-weighted magnetic resonance imaging (DW-MRI)

Magnetic resonance (MR) imaging examination of liver will be performed on a 3.0T Achieva MR scanner (Philips Medical Systems, The Netherlands). Diffusion-weighted imaging (DWI) will be performed using a single-shot echo-planar imaging during a single end expiratory breath-hold. A single observer placed circular regions of interest around 2.30 cm2 to measure mean signal intensity (SI) in the right hepatic lobe and the spleen for each b value, avoiding areas of artifact, vessels, and focal lesions. A monoexponential fit will be performed to calculate liver and spleen apparent diffusion coefficient (ADC) on the basis of ln(SI) as a function of b value, using all b values. Normalized liver ADC will be calculated as the ratio of liver ADC to spleen ADC.

Trial Locations (1)

10700

Faculty of Medicine Siriraj Hospital, Bangkoknoi

All Listed Sponsors
lead

Mahidol University

OTHER

NCT02682108 - Diffusion-weighted Imaging Magnetic Resonance for Assessing Liver Fibrosis | Biotech Hunter | Biotech Hunter